Skip header and navigation

28 records – page 1 of 3.

Document Type
Evidence Search Report
Review Code
EOC081301-01 ESR
Question Submitted
August 12, 2020
Date Completed
August 12, 2020
Status
3. Completed
Research Team
EOC
ABSTRACT: INTRODUCTION: Testing for active SARS-CoV-2 infection is a fundamental tool in the public health
Document Type
Evidence Search Report
Review Code
EOC081301-01 ESR
Question Submitted
August 12, 2020
Date Completed
August 12, 2020
Status
3. Completed
Research Team
EOC
Category
Diagnostics
Subject
Testing
Public Health
Decision Making
Priority Level
Level 3 completed within 2-3 days
Cite As
Dalidowicz, M. Is pooled testing for COVID-19 equally as reliable as individual testing and what are the optimal pool testing sizes? 2020 Aug 12; Document no.: EOC081301-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 8 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC081301 RR
Question Submitted
August 12, 2020
Date Completed
August 14, 2020
Status
3. Completed
Research Team
EOC
of pooled testing at the Nebraska Public Health Laboratory, and found that when one positive sample
Document Type
Rapid Review
Review Code
EOC081301 RR
Question Submitted
August 12, 2020
Date Completed
August 14, 2020
Status
3. Completed
Research Team
EOC
Key Findings
· Pool testing for COVID-19 can be equal to individual testing in terms of sensitivity, specificity and positive and negative prediction rates · Pooled testing is optimal for use when disease prevalence is low, as prevalence increases, optimal pool sizes decrease and efficiency is lost · At a prevalence of approximately 1%, optimal pool sizes have been found to be up to 13 · Pools of 5 were found to be equally efficient and could be done using 50% less tests up to a prevalence of 5% · Recommended for use in large scale asymptomatic screening, highest viral load occurs before symptoms so less likely to miss borderline positive in convalescent stage · Not recommended for clinical diagnostic use
Category
Diagnostics
Subject
Testing
Public Health
Decision Making
Priority Level
Level 3 completed within 2-3 days
Cite As
Badea, A; Muhajarine, N; Dalidowicz, M. Is pooled testing for COVID-19 equally as reliable as individual testing and what are the optimal pool testing sizes? 2020 Aug 14; Document no.: EOC081301 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 19 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC082502-01 ESR
Question Submitted
August 25, 2020
Date Completed
August 27, 2020
Status
3. Completed
Research Team
EOC
• MEDLINE • Public Health Agency of Canada website • SSRN • WHO Global Research on COVID-19
Document Type
Evidence Search Report
Review Code
EOC082502-01 ESR
Question Submitted
August 25, 2020
Date Completed
August 27, 2020
Status
3. Completed
Research Team
EOC
Category
Administration
Infection Prevention and Control
Subject
Infrared Thermometers
Screening
Public Health
Risk
Population
All
Priority Level
Level 3 completed within 2-3 days
Cite As
Ellsworth, C; Fox, L. Is there evidence of risks for using infrared thermometers? 2020 Aug 27; Document no.: EOC082502-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 11 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC082502 RR
Question Submitted
August 25, 2020
Date Completed
August 29, 2020
Status
3. Completed
Research Team
EOC
Document Type
Rapid Review
Review Code
EOC082502 RR
Question Submitted
August 25, 2020
Date Completed
August 29, 2020
Status
3. Completed
Research Team
EOC
Key Findings
· Infrared thermometers detect the infrared waves emitted by an object and convert into an electrical signal to display the distribution of temperature · Infrared thermometers do not emit radiation, however many are equipped with a laser tracker beam, similar to that found in television remote controls · The Pineal Gland is located deep inside the brain, separated from the forehead by the presence of the skull and several centimeters of brain tissue
Category
Administration
Infection Prevention and Control
Subject
Infrared Thermometers
Screening
Public Health
Risk
Population
All
Priority Level
Level 3 completed within 2-3 days
Cite As
Badea, A; Groot, G; Ellsworth, C; Fox, L. Is there evidence of risks for using infrared thermometers? 2020 Aug 29; Document no.: EOC082502 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 12 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Table
Review Code
EOC220102 RR Table
Question Submitted
January 10, 2022
Date Completed
February 4, 2022
Status
4. Update in progress
Research Team
EOC
of Medicine. 2021;385(26):2421-30. Research public health data analysis Israel booster data Split by age
Document Type
Table
Review Code
EOC220102 RR Table
Question Submitted
January 10, 2022
Date Completed
February 4, 2022
Status
4. Update in progress
Research Team
EOC
Category
Epidemiology
Infection Prevention and Control
Subject
Immunity
Infection Prevention and Control
Pediatrics
Public Health
Vaccination
Priority Level
Level 2 One week (7 days)
Cite As
Badea, A; Reeder, B; Groot, G; Dalidowicz, M; Fox, L. Is there evidence that children under 18 should receive an mRNA vaccine booster/3rd dose? 2022 Feb 04, Document no.: EOC220102 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2022. (CEST table).
Related Documents
Documents

EOC220102 RR Table

Download File
Less detail
Document Type
Rapid Review
Review Code
EOC220102 RR
Question Submitted
January 10, 2022
Date Completed
February 4, 2022
Status
4. Update in progress
Research Team
EOC
Public Health England  Public Health Ontario  Trip Pro  UK Health Agency  USA CDC  USA
Document Type
Rapid Review
Review Code
EOC220102 RR
Question Submitted
January 10, 2022
Date Completed
February 4, 2022
Status
4. Update in progress
Research Team
EOC
Key Findings
The CDC has released a recommendation that all adolescents 12-17 be offered booster vaccines using only the Pfizer COVID-19 vaccine, at least 5 months following the primary series
The CDC guidelines follow the review of unpublished Israeli data of 12-15 year olds vaccinated 5-6 months prior showing an equivalent infection rate to unvaccinated, and that those who receive boosters are at about 1/3 of the risk
Health Canada has not yet approved booster doses for general use in 12-17 year olds, however NACI has recommended that boosters, at least 6 months following the primary series, should be considered for the following groups within that age group o Those with an underlying medical condition at high risk of severe illness due to COVID-19 (including those who are immunocompromised and received a 3-dose primary series) o Those who are residents in congregate settings (e.g. shelters, group homes, quarters for migrant workers, correctional facilities) o Those who belong to racialized and/or marginalized communities disproportionately affected by COVID-19
Category
Epidemiology
Infection Prevention and Control
Subject
Immunity
Infection Prevention and Control
Pediatrics
Public Health
Vaccination
Priority Level
Level 2 One week (7 days)
Cite As
Badea, A; Reeder, B; Groot, G; Dalidowicz, M; Fox, L. Is there evidence that children under 18 should receive the booster to increase their immunity? 2022 Feb 04, Document no.: EOC220102 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2022. 8 p. (CEST rapid review report).
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC220102v002 ESR
Question Submitted
January 10, 2022
Date Completed
April 6, 2022
Status
4. Update in progress
Research Team
EOC
in Adolescents Aged 12-17 Years and Interim Public Health Considerations for Administration of a Booster Dose
Document Type
Evidence Search Report
Review Code
EOC220102v002 ESR
Question Submitted
January 10, 2022
Date Completed
April 6, 2022
Status
4. Update in progress
Research Team
EOC
Notes
Updated review not currently planned.
Category
Epidemiology
Infection Prevention and Control
Subject
Immunity
Infection Prevention and Control
Pediatrics
Public Health
Vaccination
Priority Level
Level 2 One week (7 days)
Cite As
Dalidowicz, M; Fox, L. Is there evidence that children under 18 should receive the booster to increase their immunity? 2022 Apr 06, Document no.: EOC220102v002 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2022. 11 p. (CEST rapid review report).
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC220301 SBAR
Question Submitted
March 1, 2022
Date Completed
May 2022
Status
3. Completed
Research Team
EOC
Deputy Minister of Health, local and provincial Medical Health Officers, Urban Public Health Network
Document Type
Rapid Review
Review Code
EOC220301 SBAR
Question Submitted
March 1, 2022
Date Completed
May 2022
Status
3. Completed
Research Team
EOC
Notes
This is not a regular rapid review. It was decided to write this SBAR instead.
Category
Healthcare Services
Subject
Vaccines
Vaccination
Public Health
Decision Making
Health Personnel
Infection Prevention and Control
Population
All
Clinical Setting
Community
Primary care
Public Health
Priority Level
Level 3 Two weeks (14 days)
Cite As
Rowein S, Singh S, Habbick M, Mehdiyeva K, Miller L, Gagneur, A, Groot G, Neudorf C, Camillo CA, Tokhmafshan, F, Muhajarine N. Motivational Interviewing for Vaccine Hesitancy. May 2022. Document no.: [12.1]. CoVaRR-Net Public Health, Health Systems, Social Policy Team, c2022.
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EPM040901-01 ESR
Question Submitted
April 9, 2020
Date Completed
April 9, 2020
Status
3. Completed
Research Team
Epidemiology & Modelling
-19-pandemic-plan-templat.pdf https://crihb.org/prevention-and-education/public-health/ https
Document Type
Evidence Search Report
Review Code
EPM040901-01 ESR
Question Submitted
April 9, 2020
Date Completed
April 9, 2020
Status
3. Completed
Research Team
Epidemiology & Modelling
Notes
Written Rapid Review was not produced.
Category
Infection Prevention and Control
Subject
Saskatchewan
Indigenous
Public Health
Population
Indigenous Peoples
Priority Level
Level 2 completed within 8 hours
Cite As
Young, C; Mueller, M. What are the best practices for COVID-19 response and control in indigenous populations in Northern Saskatchewan and in on-reserve communities? 2020 Apr 24; Document no.: EPM040901-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 24 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC081201-01 ESR
Question Submitted
August 12, 2020
Date Completed
August 12, 2020
Status
3. Completed
Research Team
EOC
transmission; ▪ other indicators that local public health officials are using to assess the status of COVID
Document Type
Evidence Search Report
Review Code
EOC081201-01 ESR
Question Submitted
August 12, 2020
Date Completed
August 12, 2020
Status
3. Completed
Research Team
EOC
Category
Administration
Epidemiology
Subject
Reopening
Schools
Transmission
Public Health
Decision Making
Population
All Pediatrics
Priority Level
Level 4 completed within 1 week
Cite As
Dalidowicz, M; Ellsworth, C. What COVID-19 community transmission indicators are used in school reopening plans? 2020 Aug 12; Document no.: EOC081201-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 12 p. (CEST evidence search report)
Related Documents
Documents
Less detail

28 records – page 1 of 3.